ZVIA Fundamental Analysis - ZEVIA PBC-A

Fundamental Rating

ZVIA gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 32 industry peers in the Beverages industry. No worries on liquidiy or solvency for ZVIA as it has an excellent financial health rating, but there are worries on the profitability. ZVIA does not seem to be growing, but still is valued expensively.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year ZVIA has reported negative net income.

In the past year ZVIA has reported a negative cash flow from operations.

ZVIA had negative earnings in each of the past 5 years.

In the past 5 years ZVIA always reported negative operating cash flow.

1.2 Ratios

ZVIA's Return On Assets of -31.31% is on the low side compared to the rest of the industry. ZVIA is outperformed by 87.50% of its industry peers.

Looking at the Return On Equity, with a value of -36.12%, ZVIA is doing worse than 84.38% of the companies in the same industry.

		Industry Rank	Sector Rank
ROA	-31.31%
ROE	-36.12%
ROIC	N/A

ROA(3y)-29.12%

ROA(5y)-27.27%

ROE(3y)-28.52%

ROE(5y)-27.7%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

ZVIA has a Gross Margin (47.48%) which is in line with its industry peers.

In the last couple of years the Gross Margin of ZVIA has remained more or less at the same level.

The Profit Margin and Operating Margin are not available for ZVIA so they could not be analyzed.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	47.48%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y1.56%

GM growth 5Y1.48%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

ZVIA does not have a ROIC to compare to the WACC, probably because it is not profitable.

The number of shares outstanding for ZVIA has been increased compared to 1 year ago.

ZVIA has more shares outstanding than it did 5 years ago.

There is no outstanding debt for ZVIA. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

ZVIA has an Altman-Z score of 16.67. This indicates that ZVIA is financially healthy and has little risk of bankruptcy at the moment.

ZVIA has a better Altman-Z score (16.67) than 93.75% of its industry peers.

ZVIA has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	N/A
Altman-Z	16.67

ROIC/WACCN/A

WACC10.11%

2.3 Liquidity

ZVIA has a Current Ratio of 2.34. This indicates that ZVIA is financially healthy and has no problem in meeting its short term obligations.

With a decent Current ratio value of 2.34, ZVIA is doing good in the industry, outperforming 71.88% of the companies in the same industry.

A Quick Ratio of 1.63 indicates that ZVIA should not have too much problems paying its short term obligations.

ZVIA has a Quick ratio of 1.63. This is amongst the best in the industry. ZVIA outperforms 84.38% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	2.34
Quick Ratio	1.63

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 45.83% over the past year.

ZVIA shows a decrease in Revenue. In the last year, the revenue decreased by -4.72%.

The Revenue has been growing by 12.62% on average over the past years. This is quite good.

EPS 1Y (TTM)45.83%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%50%

Revenue 1Y (TTM)-4.72%

Revenue growth 3Y3.91%

Revenue growth 5Y12.62%

Sales Q2Q%-2%

3.2 Future

ZVIA is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 18.66% yearly.

Based on estimates for the next years, ZVIA will show a small growth in Revenue. The Revenue will grow by 6.26% on average per year.

EPS Next Y46.7%

EPS Next 2Y29.27%

EPS Next 3Y18.67%

EPS Next 5YN/A

Revenue Next Year3.64%

Revenue Next 2Y5.19%

Revenue Next 3Y6.26%

Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

ZVIA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.

Also next year ZVIA is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

ZVIA's earnings are expected to grow with 18.66% in the coming years. This may justify a more expensive valuation.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y29.27%

EPS Next 3Y18.67%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

ZVIA does not give a dividend.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

ZEVIA PBC-A

NYSE:ZVIA (7/1/2025, 7:38:59 PM)

After market: 3.1499 +0.09 (+2.94%)

3.06

-0.16 (-4.97%)

Chartmill FA Rating

GICS SectorConsumer Staples

GICS IndustryGroupFood, Beverage & Tobacco

GICS IndustryBeverages

Earnings (Last)05-07 2025-05-07/amc

Earnings (Next)N/A N/A

Inst Owners51.39%

Inst Owner Change10.85%

Ins Owners4.81%

Ins Owner Change2.26%

Market Cap227.11M

Analysts78.33

Price Target4.21 (37.58%)

Short Float %1.25%

Short Ratio0.86

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)1

Avg EPS beat(2)21%

Min EPS beat(2)-12.04%

Max EPS beat(2)54.05%

EPS beat(4)3

Avg EPS beat(4)26.29%

Min EPS beat(4)-12.04%

Max EPS beat(4)54.05%

EPS beat(8)7

Avg EPS beat(8)20.75%

EPS beat(12)10

Avg EPS beat(12)17.86%

EPS beat(16)13

Avg EPS beat(16)7.21%

Revenue beat(2)1

Avg Revenue beat(2)-0.73%

Min Revenue beat(2)-1.79%

Max Revenue beat(2)0.34%

Revenue beat(4)2

Avg Revenue beat(4)-2.18%

Min Revenue beat(4)-9.04%

Max Revenue beat(4)1.78%

Revenue beat(8)3

Avg Revenue beat(8)-1.32%

Revenue beat(12)6

Avg Revenue beat(12)-0.06%

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)-1%

PT rev (3m)2.27%

EPS NQ rev (1m)0.68%

EPS NQ rev (3m)-2.85%

EPS NY rev (1m)1.82%

EPS NY rev (3m)28.53%

Revenue NQ rev (1m)0%

Revenue NQ rev (3m)-1.65%

Revenue NY rev (1m)0%

Revenue NY rev (3m)-1.49%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	1.47
P/FCF	N/A
P/OCF	N/A
P/B	4.23
P/tB	4.49
EV/EBITDA	N/A

EPS(TTM)-0.26

EYN/A

EPS(NY)-0.1

Fwd EYN/A

FCF(TTM)-0.01

FCFYN/A

OCF(TTM)-0.01

OCFYN/A

SpS2.08

BVpS0.72

TBVpS0.68

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-31.31%
ROE	-36.12%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	47.48%
FCFM	N/A

ROA(3y)-29.12%

ROA(5y)-27.27%

ROE(3y)-28.52%

ROE(5y)-27.7%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexcg growth 3YN/A

ROICexcg growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y1.56%

GM growth 5Y1.48%

F-Score4

Asset Turnover2.49

Health

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	20.83%
Cap/Sales	0.17%
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	2.34
Quick Ratio	1.63
Altman-Z	16.67

F-Score4

WACC10.11%

ROIC/WACCN/A

Cap/Depr(3y)104.57%

Cap/Depr(5y)142.96%

Cap/Sales(3y)0.92%

Cap/Sales(5y)1.15%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)45.83%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%50%

EPS Next Y46.7%

EPS Next 2Y29.27%

EPS Next 3Y18.67%

EPS Next 5YN/A

Revenue 1Y (TTM)-4.72%

Revenue growth 3Y3.91%

Revenue growth 5Y12.62%

Sales Q2Q%-2%

Revenue Next Year3.64%

Revenue Next 2Y5.19%

Revenue Next 3Y6.26%

Revenue Next 5YN/A

EBIT growth 1Y43.95%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year54.38%

EBIT Next 3Y28.98%

EBIT Next 5YN/A

FCF growth 1Y64.93%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y-3810%

OCF growth 3YN/A

OCF growth 5YN/A

ZEVIA PBC-A (ZVIA) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens